Image
Image
Image 2
Image 2
Image 5
Image 5
Image 3
Image 3
Image 6
Image 6
Image 4
Image 4
Pleomorphic adenomas account for 70-80% of benign salivary gland tumors and comprise the majority of parotid gland tumors (84% of all pleomorphic adenomas arise in parotid, with superficial lobe being more common).
These tumors are composed of epithelial and myoepithelial tissues with mixed histology; the pseudocapsule is delicate and incomplete with microscopic extensions, accounting for high recurrence risk (20-45%) with simple enucleation.
Three histological subtypes exist: myxoid (hypocellular, most common with highest recurrence risk), cellular, and classic; myxoid type characteristically shows very high T2 signal on MRI.
Imaging appearance often belies true pathology: despite appearing well-encapsulated on imaging, the poorly demarcated pseudocapsule can lead to significant recurrence rates if inadequate surgical margins obtained.
Modern surgical approach using partial or total parotidectomy with preservation of facial nerve has dramatically reduced recurrence rates to 1-4% compared to historical enucleation rates of 20-45%.
Malignant transformation to carcinoma ex-pleomorphic adenoma is uncommon (1-10%) but more likely in larger tumors and older patients; recurrent tumors and radiation therapy are additional risk factors for malignancy.
Describe pleomorphic adenomas as a well-circumscribed, homogeneous mass with characteristic bosselated borders and very high T2 signal (with or without a T2 hypointense fibrous capsule rim), located in the superficial lobe of the parotid gland; note the absence of perineural spread or aggressive features to distinguish from malignant mimics.